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ABSTRACT
Background. Cardiovascular risk is elevated in end-stage renal disease. Left ventricular (LV) dysfunction is linked to
repetitive transient ischaemia occurring during haemodialysis (HD). Cardiomyocyte ischaemia results in ‘cardiac stunning’,
evidenced by regional wall motion abnormalities (RWMAs). Ischaemic RWMA have been documented during HD resulting
in maladaptive cardiac remodelling and increased risk of heart failure. Intra-dialytic exercise is well tolerated and can
improve quality of life and functional capacity. It may also attenuate HD-induced cardiac stunning.
Methods. This exploratory study aimed to assess the effect of intra-dialytic cycle ergometry on cardiac stunning. Twenty
exercise-naı̈ve participants on maintenance HD (mean 6 SD, 59 6 11 years) underwent resting echocardiography and
maximal cardiopulmonary exercise testing. Subsequently, cardiac stunning was assessed with myocardial strain-derived
RWMAs at four time points during (i) standard HD and (ii) HD with 30 min of sub-maximal intra-dialytic cycle ergometry at
a workload equivalent to 90% oxygen uptake at the anaerobic threshold (VO2AT). Central haemodynamics and cardiac
troponin I were also assessed.
Results. Compared with HD alone, HD with intra-dialytic exercise significantly reduced RWMAs after 2.5 h of HD (total
110 6 4, mean 7 6 4 segments versus total 77 6 3, mean 5 6 3, respectively; P¼0.008). Global cardiac function, intra-dialytic
haemodynamics and LV volumetric parameters were not significantly altered with exercise.
Conclusions. Intra-dialytic exercise reduced cardiac stunning. Thirty minutes of sub-maximal exercise at 90% VO2AT was
sufficient to elicit acute cardio-protection. These data potentially demonstrate a novel therapeutic effect of intra-dialytic
exercise.
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Cardiovascular risk is increased in end-stage renal disease
(ESRD) [1, 2]. In addition to the direct effects of chronic kidney
disease (CKD), renal replacement therapy, such as maintenance
haemodialysis (HD), precipitates ischaemic myocardial injury
through altered cardiovascular haemodynamics [3, 4]. The re-
sultant maladaptive cardiac remodelling and left ventricular
(LV) dysfunction contribute to increased mortality, while
compromising physical function and quality of life [1, 3, 5–10].
Cardiovascular haemodynamics are acutely depressed
during HD. Rapid change in fluid volume reduces venous return
and myocardial preload, thus contractile force and cardiac out-
put are impaired [1, 11, 12]. The latter can decrease by as much
as 1.5 L/min, increasing the risk of intra-dialytic hypotension
[20 mmHg decrease in systolic blood pressure (SBP) and/or
10 mmHg decrease in mean arterial pressure], which occurs in
20–30% of HD treatments [13, 14]. This haemodynamic instabil-
ity and systemic hypoperfusion can lead to ischaemic injury
of gastrointestinal, cerebral and myocardial tissues [1, 9, 15].
Acute sub-clinical myocardial ischaemia during HD, or ‘car-
diac stunning’, has been confirmed with magnetic resonance
imaging and echocardiographic myocardial strain imaging
through the identification of regional wall motion abnormalities
(RWMAs) [1]. Myocardial ischaemia during HD has both acute
and chronic consequences; ultimately, recurrent ischaemic in-
jury, indicated by increased RWMA or cardiac troponin, pro-
motes fibrotic cardiac remodelling and eventual heart failure [1,
11]. Medical interventions may include ultrafiltration profiling,
haemodiafiltration and cooled dialysate [16]. Despite these, hae-
modynamic instability and cardiac stunning during HD are
common and problematic, thus alternative therapeutic options
must be explored [16].
When undertaken regularly, intra-dialytic exercise training,
such as cycle ergometry, can improve aerobic capacity, quality
of life and dialysis efficacy [17–21]. It may also confer immediate
cardio-protection by increasing myocardial perfusion [16].
Acutely, exercise elevates cardiac output and increases O2 deliv-
ery to active tissue [22]. This physiological state may promote
haemodynamic stability during HD, thus sustaining coronary
perfusion and preventing ischaemic cardiac stunning.
Alternatively, ischaemic preconditioning may occur, whereby
repetitive, sub-clinical ischaemia during intra-dialytic exercise
may ultimately increase cardiomyocyte resistance to hypoxia
[21]. There is limited research investigating the acute effects of
intra-dialytic exercise on cardiac stunning.
Ischaemic cardiac stunning is an unfortunate consequence
of essential HD treatment. The acute haemodynamic response
to intra-dialytic exercise may attenuate or prevent cardiac stun-
ning through increased myocardial perfusion or ischaemic pre-
conditioning. Intra-dialytic exercise may prove to be a viable
therapeutic strategy to reduce the considerable cardiovascular
burden associated with CKD and its treatment. Consequently,
this exploratory study aimed to assess the acute effect of intra-
dialytic exercise on cardiac stunning. We hypothesized that car-
diac stunning would be acutely reduced during maintenance
HD with intra-dialytic exercise.
MATERIALS AND METHODS
In this exploratory prospective cohort study, 20 participants
with ESRD were recruited from University Hospital Coventry
and Warwickshire NHS Trust, between May 2017 and December
2018. After cardiopulmonary exercise testing (CPET) and resting
transthoracic echocardiography on a non-dialysis day, partici-
pants were assessed under two different conditions: (i) a standard
HD session (HD) and (ii) 30 min of objectively prescribed intra-
dialytic constant load exercise (HDþCLE). Echocardiography and
blood pressure (BP) monitoring were performed at four time
points: (i) immediately before HD (pre-HD); (ii) after 1 h of HD had
elapsed (1 h-HD); (iii) after 1.5 h of HD (1.5 h-HD); and (iv) after
2.5 h of HD (2.5 h-HD) (Figure 1).
Participants
Untrained adults with HD vintage >3 months, undergoing three
times weekly HD, with a urea reduction rate of at least 65%, and
able to cycle during HD, were included. Exclusion criteria in-
cluded clinically significant valvular insufficiency or dysrhyth-
mia, intra-dialytic BP> 180 systolic or >95 diastolic, >3 L fluid
accumulation between HD sessions, haemoglobin <9.0 g/dL,
ischaemic cardiac event (<1 month) or planned kidney trans-
plant during the study. This study was approved by the Health
Research Ethics Committee (17/LO/0368) and registered with
ClinicalTrials.gov (NCT03064555). Written informed consent
was obtained from all participants.
Echocardiogram
To assess global longitudinal strain (GLS) and RWMAs, echocar-
diography (Vivid IQ, GE Medical Systems) was performed by a
trained researcher. Acquisition of apical two, three and four-
chamber images (Figure 2), over three cardiac cycles, allowed
quantification of GLS using automated function imaging.
Endocardial wall motion was semi-automatically tracked with
speckle tracking software (Echo-pack version 7.0, GE Medical
Systems) and strain calculated as:
e tð Þ ¼ L t
ð Þ – Lðt0Þ
L t0ð Þ
where L(t) is the length at the time instance t and L(t0) indicates
baseline length. Instantaneous deformation was expressed rela-
tive to initial length [23], with lower negative values indicating
greater LV deformation (i.e. 20% indicates greater deformation
than 10%). A 17-segment model (‘bullseye’, Figure 3) was used
to identify RWMAs, with a 20% relative reduction in strain from
baseline, for each myocardial segment, indicating a RWMA [1].
Two- and four-chamber views also allowed measurement of LV
volumetric parameters with Simpson’s biplane method [23].
Heart rate (HR) was determined via ECG.
Data collection
For consistency, and to limit the haemodynamic effects of
2-day fluid accumulation, both testing sessions were performed
FIGURE 1: Schematic for HD and HDþCLE tests. Black bars indicate data collec-
tion time points: (i) pre-HD; (ii) 1 h-HD (pre-exercise); (iii) 1.5 h-HD (post-exer-
cise); and (iv) 2.5 h-HD (1 h post-exercise). Dashed box indicates cycle ergometry
during HDþCLE. Echo, echocardiogram.
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after a single non-dialysis day. During HD, and subsequently dur-
ing HDþCLE test, LV function and central haemodynamics were
assessed with transthoracic echocardiography and automated BP
on the upper, non-fistula arm (Cheetah Medical, Maidenhead,
UK), respectively, at four time points: (i) pre-HD; (ii) after 1 h-HD
had elapsed; (iii) after 1.5 h-HD; and (iv) after 2.5 h-HD (Figure 1).
CPET
Maximal CPET was undertaken 1 week prior to data collection
using an electronically braked cycle ergometer (Ergoline, Love
Medical, Manchester, UK). A standard ramp protocol was
employed with incremental load adjustment of 5, 10, 15 or
20 W/min to ensure optimal duration of 9–12 min. Participants
were encouraged to maintain a cadence of 70 r.p.m. until volun-
tary exhaustion, indicated by a respiratory exchange ratio >1.15
[24]. Breath by breath analysis was carried out using a respira-
tory gas analysis system (Ergospirometer, Ergostik, Geratherm
Respiratory, Bad Kissingen, Germany), whereby measurements
of oxygen uptake (VO2) and carbon dioxide production (VCO2)
were recorded, allowing identification of oxygen uptake at the
anaerobic threshold (VO2AT) with the V-Slope method [22, 25].
Data from CPET were used to accurately determine exercise in-
tensity for the subsequent HDþCLE test.
HD
All participants were dialysing three times weekly for 4–5 h per
session. Ultrafiltration rate was determined clinically, depen-
dent on fluid accumulation between dialysis sessions. To limit
differences in LV preload and cardiac output between tests,
thereby allowing standardized comparison of haemodynamic
responses, participants were encouraged to maintain fluid in-
take within clinically prescribed thresholds. HD filtration rates
were the same for HD and HDþCLE tests, unless otherwise clin-
ically directed.
Intra-dialytic CLE (HD 1 CLE) test
CLE was performed in the semi-recumbent position on an elec-
tronically braked cycle ergometer (Lower body bi-directional
ergometer, Hudson Fitness, Dallas, TX, USA). Workload was ad-
justed with pedal resistance and cadence. After a 5-min warm-
FIGURE 2: Typical echocardiogram assessment during HD. (A) Apical four-chamber view, (B) apical two-chamber view, (C) apical three-chamber view. Images A and B
were used to calculate LV stroke volume, cardiac output, ejection fraction and end-diastolic and -systolic volumes with the Simpson’s biplane method. Images A–C
were used for GLS and RWMA assessment, and subsequently, a bullseye plot was produced (D). Dark grey indicates higher longitudinal strain with light grey and white
indicating progressively lower longitudinal strain (hypokinesia). A score of 0 (white) indicates myocardial segment akinesia.
FIGURE 3: Regional bullseye plot of the left ventricle for identification of longitu-
dinal strain and RWMAs. Each segment represents local myocardial function.
ANT, anterior; LAT, lateral; POST, posterior; INF, inferior; SEPT, septal; ANT-SEP,
anterior septal.
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up at 10 r.p.m. below testing r.p.m., 30 min of exercise was com-
pleted at a workload (Watts) equivalent to 90% VO2AT, pre-de-
termined from CPET. On completion, participants ‘cooled down’
with 3 min of unloaded pedalling at 50 r.p.m.
Cardiac troponin I
One plasma vacutainer (3 mL) was collected at 1 h-HD, 1.5 h-HD
and 2.5 h-HD during both the HD and HDþCLE conditions.
Pre-HD samples were not possible due to patient preparation
for dialysis. Samples were centrifuged at 3000 r.p.m. at 21C
(Sigma 3-18 k Scientific Laboratory Supplies) and frozen at
80C for subsequent analysis. Troponin I was assessed with
commercially available sandwich enzyme-linked immunoassay
kits (Abbexa, Cambridge, UK; abx252868; biotin conjugated anti-
body; sensitivity 9.38 pg/mL). Serial dilutions were performed
ranging from 15.63 to 1000 pg/mL. Absorbance was measured
at 450 nm wavelength. Sample concentration was determined
using linear regression from pre-determined standard
concentrations.
Sample size
Due to the exploratory nature of the study, an a priori power cal-
culation was not possible. Therefore, 20 participants were
recruited. Retrospective analysis of effect size for RWMAs was
determined using Cohen’s d.
Statistical analysis
Data were analysed with a two-way ANOVA within subjects for
condition (HD and HDþCLE) and time (pre-HD, 1 h-HD, 1.5 h-HD
and 2.5 h-HD). Where a main effect effect was identified, post
hoc analysis was undertaken with a paired sample t-test. All
data were expressed as mean 6 SD. To correct violations of
sphericity, degrees of freedom were adjusted using
Greenhouse–Geisser (<0.75) or Huynh–Feldt (>0.75) where ap-
propriate. Statistical significance was indicated by P< 0.05.
RESULTS
From May 2017 to December 2018, 70 patients were screened, of
which 40 were eligible and 20 agreed to participate. Due to poor
visualization of the lateral endocardial border, preventing accu-
rate speckle tracking in two echocardiography assessments, 18
participants were included in the final analysis. Participants
acted as their own controls by undertaking HD and HDþCLE
testing separated by 1 week. HD and intra-dialytic exercise were
well tolerated; one participant experienced peripheral fatigue,
stopping twice during HDþCLE for 2 min, and two participants
felt ‘light headed’ during the post-exercise period. Unplanned
medical intervention was not required during or after any of the
tests. All participants completed 30 min of cycling at 90% VO2AT
(mean workload 35 6 10 W) after 1 h of HD had elapsed.
Medication was not altered for the duration that each partici-
pant was enrolled in this study.
Baseline characteristics
Baseline characteristics are presented in Table 1. The mean age
was 59 6 11 years with females constituting 27% of participants.
Mean dry weight was 72 6 11 kg, and body mass index (BMI) was
24.4 6 3.2 kg/m2. HD vintage was 36 6 40 months, with the most
common CKD aetiologies being diabetic nephropathy (22%) and
glomerular nephritis (22%).
HD parameters
There were no significant differences between tests for HD
duration, post-HD weight or symptoms (Table 2). HD filtration
volume (2422 6 697 versus 2028 6 799 mL), filtration rate
(589 6 139 versus 469 6 209 mL) and pre-weight (74.4 6 13.5 ver-
sus 73.4 6 13.5 kg) varied slightly between HD and HDþCLE
(Table 2).
Cardiac function
GLS progressively declined (P¼ 0.012) in all 18 participants dur-
ing both HD (14 6 2 pre-HD to 13 6 3% at 2.5 h-HD) and
HDþCLE (14 6 4 pre-HD to 13 6 4% at 2.5 h-HD) indicating de-
creased myocardial function. There was no difference between
HD and HDþCLE in the reduction in GLS (P¼ 0.489; Figure 4).
RWMAs were identified in all 18 participants during HD and
HDþCLE (Figure 4). The total number of RWMAs identified
increased during HD to a maximum of 110 6 4 segments at
2.5 h-HD. During HDþCLE, the total number of RWMAs identified
increased to a maximum of 106 6 3 segments at 1.5 h-HD. At the
2.5 h-HD timepoint, there were significantly fewer RMWAs during
HDþCLE compared with HD (total 77 6 3, mean 5 6 3 versus total
110 6 4, mean 7 6 4 segments, respectively; P¼ 0.008). The great-
est number of RWMAs occurred in the mid inferolateral and
basolateral segments for HD and HDþCLE (Figure 5).
Cardiac output decreased (P< 0.001) by 21% during HD
(4.6 6 1.6 L/min pre-HD to 3.6 6 1.7 L/min at 2.5 h-HD) and by 20%
during HDþCLE (4.5 6 1.5 L/min pre-HD to 3.6 6 1.3 L/min at
2.5 h-HD). There was no difference (P¼ 0.645) in the reduction in
cardiac output between HD and HDþCLE (Figure 4).
HR increased during HDþCLE (77 6 10 b.p.m. pre-HD to
87 6 15 b.p.m. at 1.5 h-HD; P¼ 0.022). There was a significant dif-
ference (P¼ 0.024) in HR between HD and HDþCLE at the 1.5 h-
HD time point (Figure 4).
LV end-diastolic volume decreased (P¼ 0.014) by 17% during
HD (135 6 54 mL pre-HD to 112 6 50 mL at 2.5 h-HD), and by 10%
during HDþCLE (118 6 46 mL pre-HD to 106 6 51 mL at 2.5 h-
HD). There was no difference (P¼ 0.289) between HD and
HDþCLE in terms of the reduction in LV end-diastolic volume
(Figure 4).
LV end-systolic volume (P¼ 0.53), ejection fraction (P¼ 0.125)
and stroke volume (P¼ 0.206) did not change during HD or
HDþCLE, nor were there any differences between the HD and
HDþCLE conditions.
Troponin I
Cardiac troponin I did not differ over time (P¼ 0.172) during HD
or HDþCLE, nor was there any difference between HD and
HDþCLE (P¼ 0.139; Figure 4).
Haemodynamics
There were no statistically significant changes in SBP (P¼ 0.262),
DBP (P¼ 0.092) or mean arterial pressure (MAP) (P¼ 0.651) over
the duration of HD and HDþCLE, and there were no differences
between the HD and HDþCLE conditions (Figure 6). However,
there was a trend towards a difference in MAP between
HDþCLE and HD (P¼ 0.052).
Effect size analysis
Retrospective analysis identified a moderate effect size (0.57) for
RWMAs in 18 participants at the 2.5 h-HD time point [26] with a
mean of 5 6 3 segments for HDþCLE and 7 6 4 segments for HD.










This exploratory study assessed the acute effect of cycle ergometry
performed during maintenance HD. We report a significant reduc-
tion in cardiac stunning with intra-dialytic exercise, compared
with HD without exercise. These data extend previous findings by
objectively quantifying a duration and intensity of exercise (30 min
at a workload equivalent to 90% VO2AT) sufficient to provoke a re-
duction in cardiac stunning in exercise- naı̈ve HD patients.
HD
Data from this study indicate that HD elicited a physiological
and haemodynamic response consistent with previous reports
[1, 9]. GLS, cardiac output and LV end-diastolic volume
decreased significantly throughout HD. Simultaneously, the
number of RWMAs increased, particularly between the 1.5 and
2.5 h-HD timepoints. Although not statistically significant, other
LV volumetric and haemodynamic parameters appeared to
decline throughout HD. Overall, this haemodynamic profile is
typical of HD, relating to a steady decline in plasma volume dur-
ing filtration, thus reduced LV preload and contractility [31].
With HD treatment, cardiovascular function deteriorates [1];
as cardiac output declines, so too does coronary blood flow [9],
with resultant myocardial ischaemia. We observed an increase
in RWMAs during HD, likely resulting from reduced coronary
blood flow and cardiomyocyte hypoxia [1]. Predominantly,
RWMAs during HD are indicative of myocardial ischaemia
and are considered to be a key driver of heart failure [27], and
thus increased mortality. Chronic, repetitive myocardial ischae-
mia can eventually lead to increased cardiomyocyte apoptosis
and necrosis, a key determinant of myocardial fibrosis [1]. Acute
stunning of myocardial segments also impairs haemodynamic
stability, potentially reducing HD efficacy. Cardiac function is
inevitably affected, manifesting as chronic LV systolic and dia-
stolic impairment [1]. Previous work showed that 12 months of
HD in patients with observable RWMAs resulted in an 8.6%
decrease in LV ejection fraction [1], and in the longer term is
associated with heart failure, and decreased survival and qual-
ity of life [1, 6, 9]. Preserving cardiac function and reducing the
cardiovascular risks associated with HD are paramount.
Intra-dialytic exercise
GLS gradually declined during both experimental conditions in
our study, corresponding with an increase in RWMAs. However,
intra-dialytic exercise was associated with a significant reduc-
tion in RWMAs at 2.5 h-HD compared with HD without exercise.
This is a key finding, illustrating the potential for intra-dialytic
exercise to attenuate cardiac stunning. In a previous study,
Penny et al. [21] also reported reduced RWMAs with intra-
dialytic exercise in an HD cohort regularly undertaking intra-
dialytic cycle ergometry as part of a clinical service. Our study
extends these findings to an untrained HD population in which
maximal exercise capacity was directly measured with CPET
and subsequently used to individually prescribe exercise at a
workload equivalent to 90% VO2AT.
It is notable that, despite reduced RWMA during HDþCLE, a
progressive and comparable decline in GLS was evident during
both conditions. Therefore, global LV function was not visibly
Table 1. Participant characteristics
Participant characteristics ESRD (n¼ 18)
Age, years 59 6 11
Weight, kg 72 6 11
Height, cm 172 6 11
BMI, kg/m2 24.4 6 3.2
Gender, n (male/female) 13/5










Coronary artery disease 6 (33)
Claudication 1 (6)
Heart failure 2 (11)
Hyperparathyroidism 5 (28)
CKD aetiology, n (%)
Congenital 1 (6)
Chronic ureteric obstruction 1 (6)
Atypical haemolytic uraemic syndrome 1 (6)
Glomerular nephritis 4 (22)
Tubular necrosis 1 (6)
Good pasture syndrome 1 (6)
Renal carcinoma 1 (6)
Polycystic kidney disease 1 (6)
Diabetic nephropathy 4 (22)
Hypertensive nephropathy 1 (6)
Immunoglobulin A nephropathy 2 (11)
Medication, n (%)







Calcium channel blockers 11 (61)
b-blockers 10 (56)




Values expressed as mean6 SD where appropriate. An independent t-test was used
to identify differences between groups. eGFR, estimated glomerular filtration rate;
COPD, chronic obstructive pulmonary disease; ACE, angiotensin-converting enzyme.
Table 2. HD parameters
HD parameters HD (n¼ 18) HDþCLE (n¼ 18) P-value
Weight, kg
Pre-HD 74.4 6 13.5a 73.4 6 13.5a 0.013a
Post-HD 72.1 6 13.8 71.6 6 13.8 0.152
Duration, h:min 04:00 6 00:39 04:00 6 00:38 0.331
Filtration volume, mL 2422 6 697a 2028 6 799a 0.001a
Filtration rate, mL/h 589 6 139a 469 6 209a 0.001a
Symptoms, n (%) – – 0.163
Dizziness 2 (11) 2 (11) –
Muscle cramps 0 1 (6) –
Fatigue 0 1 (6) –
Values are expressed as mean 6 SD.
aSignificant difference between HD and HD þ CLE.
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improved, despite reduced RWMAs. This may suggest a greater
contribution to GLS of previously hypokinetic segments during
HDþCLE and, similarly, a lesser contribution of previously hy-
perkinetic segments. Thus, LV function was acutely maintained
but with a more uniform distribution of myocardial work.
It is also notable that filtration rates and volumes were
higher during the HD condition, compared with HDþCLE, both
of which are associated with a greater prevalence of RWMAs
[13]. However, this difference did not correspond to greater
RWMAs at the 1 h-HD and 1.5 h-HD time points, rather, RMWAs
occurred equally during both HDþCLE and HD. Additionally, al-
most identical haemodynamic and cardiac responses were ob-
served at these time points during the HDþCLE and HD
conditions. Only HR at 1.5 h-HD and RWMAs at 2.5 h-HD were
different between conditions. Therefore, the higher filtration
volume and rate in the HD group were not associated with
greater impairment in cardiac function and, as such, were un-
likely to have contributed to the finding of lower RWMAs at the
2.5-HD time point. Our data also agree with previous findings of
reduced RWMAs with intra-dialytic exercise during HD [21].
To assess the potential for myocardial injury with intra-
dialytic exercise, we measured cardiac troponin I. In agreement
with previous findings [28], we did not observe any significant
increase in cardiac troponin I with intra-dialytic exercise.
However, the clinical significance of these findings is unclear.
Meaningful assessment of cardiac troponin I was hindered by
the small sample, large intra-individual variability and limited
post-exercise measurement time points.
Ischaemic preconditioning
Intra-dialytic exercise reduced cardiac stunning at the 2.5 h-HD
time point as evidenced by a reduction in RWMAs. We previ-
ously speculated that acutely augmenting venous return, LV
preload and catecholamine-mediated redistribution of blood
flow with intra-dialytic exercise may improve haemodynamic
stability and coronary perfusion [16]. However, the observed
reduction in RWMAs was not accompanied by greater
haemodynamic stability measured with BP and LV volumetric
parameters. There were no differences in any of these variables
FIGURE 4: Cardiac function and troponin I during HD and HDþCLE conditions. Filled diamond indicates HDþCLE condition; filled square indicates HD condition. (A)
HR, (B) ejection fraction, (C) cardiac output, (D) stroke volume, (E) LV end-diastolic volume, (F) LV end-systolic volume, (G) mean RWMAs, (H) GLS and (I) cardiac tropo-
nin I. Grey boxes indicate 30-min exercise period for HDþCLE. *Significant difference between HDþCLE and HD conditions.
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between conditions, indicating no obvious effect of exercise on
the intra-dialytic haemodynamic profile. This corroborates the
findings of Penny et al. [21], which showed no acute effect of
intra-dialytic exercise on global cardiac function or BP. We can-
not completely rule out enhanced coronary perfusion as a
mechanism for decreased RMWAs in our study, as we did not
perform any direct measures. However, given the lack of any
difference in haemodynamic profiles between conditions, it is
more likely that other mechanisms were responsible.
Recently, an ischaemic preconditioning effect was proposed
with intra-dialytic exercise [21]. Data from our study closely re-
flect this work, thus the reduction in RWMA we observed with
exercise may be a result of this phenomenon. Acute bouts of ex-
ercise-induced hypoxia can elicit a cardio-protective effect for
up to 5 days [29]. This has been demonstrated in rat models,
whereby exercise preconditioning reduced myocardial infarc-
tion size by increasing cardiomyocyte resistance to hypoxia.
The molecular cascade eliciting this cardio-protective effect is
poorly understood. However, proposed mechanisms include ac-
celerated recovery of myocardial oxygenation, sustained upre-
gulation of cardiac endothelial nitric oxide synthase, altered
glycogen synthase kinase-3b, epidermal growth factor expres-
sion, improved contractile performance during reperfusion and
heat shock protein expression [29]. The effects of ischaemic
preconditioning are likely multifaceted. Identifying the molecu-
lar pathway responsible for this cardio-protective effect may be
critical to understanding the mechanism of reduced cardiac
stunning with intra-dialytic exercise.
Limitations
A number of limitations should be addressed. First, the study
was exploratory to demonstrate proof of concept in a small
predominantly male cohort; data should be interpreted in this
context. However, by objectively assessing and prescribing exer-
cise intensity, we were able to control for important confound-
ing factors. Secondly, despite identification of a moderate effect
size for RWMAs, it is unlikely that all variables were powered to
detect change with n¼ 18 participants. Nevertheless, similar
work proposed a sample size of 10 as sufficient to detect a 20%
change in RWMAs [21], our primary variable of interest. Finally,
we acknowledge the difference in filtration rates between con-
ditions. However, it is very unlikely that this was responsible for
the difference in RWMAs witnessed at 2.5 h-HD as there was no
difference observed at the 1 h-HD and 1.5 h-HD time points.
Regulation of filtration volume would avoid this limitation but
this was not feasible on ethical grounds; patient care was at the
discretion of the medical team.
CONCLUSION
Thirty minutes of intra-dialytic cycle ergometry, at an individu-
ally prescribed workload equivalent to 90% VO2AT, significantly
reduced cardiac stunning in a cohort of untrained participants
undergoing maintenance HD. Our exploratory study is the first
to identify the intensity and duration of exercise sufficient to
elicit this acute cardio-protective response. These data further
confirm the importance and clinical relevance of intra-dialytic
exercise. To inform intra-dialytic exercise prescription guide-
lines, future work should endeavour to investigate the optimum
tolerable intensity, timing and duration of exercise to induce
the greatest magnitude of RWMA reduction. Clinical trials are
required to assess the long-term effects of reduced cardiac
stunning during HD, not only in relation to hard clinical end-
points, but also in relation to patient-reported outcomes. Our
data suggest that intra-dialytic exercise may be acutely cardio-
protective and, accordingly, should be routinely prescribed.
FIGURE 4: Continued
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FIGURE 5: Mean regional longitudinal strain of the LV demonstrated using bullseye plots during pre-HD (A and B), 1 h-HD (C and D), 1.5 h-HD (E and F) and 2.5 h-HD (G
and H) for HD (left column) and HDþCLE (right column). Dark grey indicates higher longitudinal strain, light grey indicates lower longitudinal strain (hypokinesia). For
a detailed explanation of each segment and its myocardial representation, see Figure 3.
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